Search Results - "Padovan M"

Financial analysis of a complex agroforestry system for environmental restoration purpose in the Brazilian Rainforest.

Authors: Padovan, M. P. Nogueira, F. F. Ruas, F. G. et al.

Source: Agroforestry Systems. Feb2022, Vol. 96 Issue 2, p235-248. 14p.

714eP Medulloblastoma diagnosis in adults: A monocentric retrospective experience.

Authors: Cerretti, G. Padovan, M. Caccese, M. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS502-S503. 2p.

690P Systemic treatment in meningioma: Still an unmet need.

Authors: Cerretti, G. Padovan, M. Caccese, M. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS494-S495. 2p.

687P Targeted therapy in adult BRAF-mutant and NTRK-fusion glioblastomas and comparison with NTRK-fusion pediatric high-grade gliomas.

Authors: Cella, E. Padovan, M. Bosio, A. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS493-S494. 2p.

Alumina-supported copper chloride.

Authors: Leofanti, G. Padovan, M. Garilli, M.

Source: Journal of Catalysis; January 1 2000, Vol. 189 Issue 1, p105-116, 12p

Brain unidentified bright objects (“UBO”) in systemic lupus erythematosus: sometimes they come back. A study of microembolism by cMRI and Transcranial Doppler ultrasound.

Authors: Bortoluzzi, A. Padovan, M. Azzini, C. et al.

Source: Lupus. Feb2016, Vol. 25 Issue 2, p193-198. 6p. 2 Charts.

Root distribution and water use in coffee shaded with Tabebuia rosea Bertol. and Simarouba glauca DC. compared to full sun coffee in sub-optimal environmental conditions.

Authors: Padovan, M. Cortez, V. Navarrete, L. et al.

Source: Agroforestry Systems. Oct2015, Vol. 89 Issue 5, p857-868. 12p.

660MO A phase I, first-in-human study of regorafenib plus temozolomide with or without radiotherapy in patients with newly diagnosed MGMT methylated, IDH wildtype glioblastoma: The REGOMA-2 trial.

Authors: Padovan, M. Simonelli, M. De Nicolò, A. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS482-S482. 1p.

478P Molecular characterization of adult non-glioblastoma central nervous system (CNS) tumors to identify potential targettable alterations.

Authors: Padovan, M. Bosio, A. Cella, E. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS419-S420. 2p.

This result is not displayed to guests.
Login for full access.

461P Effectiveness of dabrafenib-trametinib and larotrectinib in adult recurrent glioblastoma patients: A real-life cohort analysis from 3 Italian centers.

Authors: Padovan, M. Cella, E. Bosio, A. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS414-S414. 1p.

Single photon emission computed tomography and magnetic resonance imaging evaluation in SLE patients with and without neuropsychiatric involvement.

Authors: Castellino, G. Padovan, M. Bortoluzzi, A. et al.

Source: Rheumatology. Mar2008, Vol. 47 Issue 3, p319-323. 5p. 6 Charts.

CNS involvement in primary Sjögren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach.

Authors: Govoni, M. Padovan, M. Rizzo, N. et al.

Source: CNS Drugs. 2001, Vol. 15 Issue 8, p597-607. 11p. 1 Color Photograph, 2 Charts.

Subjects: Central nervous system, Diagnosis of brain diseases, Brain disease treatment, Brain diseases, Sjogren's syndrome, Disease prevalence, Disease complications

369MO Final results of depatuxizumab mafodotin plus temozolomide in recurrent glioblastoma patients: Real-world experience from a multicenter study of Italian Association of Neuro-Oncology (AINO).

Authors: Padovan, M. Eoli, M. Pellerino, A. et al.

Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS399-S400. 2p.

297P The genetic profile of primary and recurrent gliomas: A mono-institutional experience using next-generation sequencing.

Authors: Padovan, M. Maccari, M. Vizzaccaro, S. et al.

Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS674-S674. 1p.

289MO Next-generation sequencing (NGS) for identifying actionable molecular alterations in newly diagnosed and recurrent IDHwt-glioblastoma (GBM) patients: A large mono institutional experience.

Authors: Padovan, M. Maccari, M. Bosio, A. et al.

Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS671-S671. 1p.

This result is not displayed to guests.
Login for full access.

Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study.

Authors: Bosio, A. Cerretti, G. Padovan, M. et al.

Source: Clinical Oncology. May2023, Vol. 35 Issue 5, pe319-e327. 9p.

Repeated brain conventional MRI and SPECT evaluation in systemic lupus erythematosus patients with and without neuropsychiatric involvement: a follow up study.

Authors: Castellino, G Bortoluzzi, A Padovan, M et al.

Source: Lupus. Dec2011, Vol. 20 Issue 13, p1387-1395. 9p. 5 Charts, 1 Graph.

700P Long-term outcomes and molecularly-guided management of adult medulloblastoma: Data from a single-institution experience.

Authors: Bosio, A. Maccari, M. Padovan, M. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS498-S498. 1p.